Key result
A model using hypertension, minimum HR, SDNN, and deceleration capacity predicts cardioinhibitory VVS with AUC ~0.77.
Why the study?
The characteristics of autonomic function indicators across different vasovagal syncope subtypes remain unclear.
Can autonomic function indicators and clinical history predict a cardioinhibitory response in patients with vasovagal syncope?
Observational (n=253)
Can autonomic function indicators and clinical history predict a cardioinhibitory response in patients with vasovagal syncope?
Deceleration capacity and selected clinical/Holter variables can moderately predict cardioinhibitory vasovagal syncope, offering a potential non-invasive diagnostic adjunct to tilt testing.
Answers are grounded in this paper and cite their sources.
May aid non-invasive identification of cardioinhibitory VVS; hypothesis-generating and requires prospective validation.
Background Patients with vasovagal syncope (VVS) exhibit a cardioinhibitory response, which is thought to be associated with enhanced parasympathetic activity.[1] However, the characteristics of autonomic function indicators across different VVS subtypes remain unclear.[2] Purpose This study aimed to assess autonomic function indicators associated with cardioinhibitory VVS and to evaluate the diagnostic value of these indicators in VVS. Methods Medical history and autonomic function data were retrospectively collected from VVS patients who had a positive head-up tilt test. Univariate, multivariate, and least absolute shrinkage and selection operator (Lasso) regression analyses were performed to identify variables associated with cardioinhibitory VVS and to develop a predictive model. The model’s performance was assessed in a randomly selected internal test set using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analysis. Results A total of 253 patients were included in the study, comprising 65 (25.7%) with cardioinhibitory VVS, 37 (14.6%) with vasodepressive VVS, and 151 (59.7%) with mixed VVS. Regression analyses comparing the cardioinhibitory and vasodepressive groups showed no significant differences in heart rate variability (HRV) (all p > 0.05). However, deceleration capacity (DC) (p = 0.004) differed significantly between the two groups, and the optimal cut-off value was 10.27 ms. Hypertension (p = 0.010), minimum heart rate (p < 0.001), standard deviation of all average normal-to- normal intervals (SDNN) (p < 0.001), and DC (p < 0.001) were significantly different between the cardioinhibitory and non-cardioinhibitory groups and were used to generate the Lasso model. The model showed a moderate AUC of 0.765(0.644-0.887) in the test set, with a good calibration curve and positive net benefits. Conclusions Parasympathetic activity was significantly increased in cardioinhibitory VVS. DC showed a stronger ability than HRV to differentiate VVS subtypes. A practical model based on clinical history and Holter data can predicts VVS patients with a cardioinhibitory response.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted an observational in Vasovagal syncope (n=253). Autonomic function indicators and clinical history vs. Non-cardioinhibitory VVS was evaluated on Prediction of cardioinhibitory VVS (AUC 0.765, 95% CI 0.644-0.887). A prediction model based on clinical history and Holter data (including deceleration capacity) identified cardioinhibitory vasovagal syncope with an AUC of 0.765.
Synapse has enriched 10 related papers. Consider them for comparative context: